Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Sime Darby Plantation Bhd. engages in the production, processing, refining, and sales of palm oil and palm kernel oil, manufacturing and marketing of specialty fats and edible oils, rubber and other palm oil related products and investment holding. It operates through the following segments: Upstream Malaysia, Upstream Indonesia, Upstream Papua New Guinea and Solomon Island (PNG/SI), Downstream, and Other Operations. The Upstream Malaysia segment develops, cultivates, and manages oil palm and rubber plantation estates and milling of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernel (PK), processing and sales of rubber. The Upstream Indonesia segment refers to the development, cultivation, and management of oil palm plantation estates, and milling of FFB into CPO and PK. The Upstream PNG/SI segment consists of the oil palm and sugar cane plantation estates, milling of FFB into CPO and PK, and refining of sugar cane, coconut oil, cattle rearing, and beef production. The Downstream segment is involved in the production and sale of refined oils and fats, coconut oils, biodiesel products, crude palm kernel oil, and palm kernel expeller. The Other Operations segment refers to the trading of agricultural products and services, production and sale of oil palm seeds and seedlings, sale of oleochemical products, research and breeding programs of oil palm and rubber, and development of green technology and renewable energy, which includes bio-based chemicals, biogas, and composting. The company was founded in 2007 and is headquartered in Petaling Jaya, Malaysia.

Part of Arches Holdings, Inc., Ancestry.com DNA LLC is a company headquartered in Provo, UT. The firm provides online network services for connecting families.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Bioyong Technology, Inc. (doing business as Beijing Yi Xinbo Chuang Biotechnology Co., Ltd.) is a Chinese private company located in Changping. The firm develops mass spectrometry technologies.

Établissement Français du Sang collects, prepares, qualifies and distributes blood transfusion products. The company is headquartered in Saint-Denis, France.

Beijing Zhicheng Biomedical Technology Co., Ltd., established on 2014-04-09, Business scope includes medical research and experimental development;technology development,technology transfer,technical consulting,Technical Services;selling computers,Software and Auxiliary Equipment,Equipment,Class Ι medical device,Class II,daily necessities,Chemical Products,electronic product,Instrumentation;Natural science research and experimental development;Agricultural Science R&D and Experimental Development;internet data service(Data Centers in Internet Data Services,PUEvalue in1.4Except for the above cloud computing data centers);Information processing and storage support services(Data centers in information processing and storage support services,PUEvalue in1.4Except for the above cloud computing data centers);repair computer;Basic software service;Application software service;software development;Machinery and Equipment Leasing;Conference Services;Undertake exhibition and display activities;Advertising Design,make;translation service;Medical Research Economic Information Consulting;computer animation design;computer graphic design;Business Management Consulting;Health Advisory(Except for medical treatment activities subject to approval).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanogen, Inc., a diagnostics company, engages in developing, manufacturing, and selling diagnostic products for use in the in vitro diagnostic market in the United States, Canada, and Europe. It offers diagnostic test kits and reagents based on polymerase chain reaction (PCR) technology in the molecular diagnostic market. The company’s PCR molecular product lines comprise Q-PCR Alert products for in-vitro diagnostic use, and are sold in Italy via a contract sales force and in other European countries through a network of distributors; and MGB Alert products. It also offers point-of-care products, which include qualitative cardiac test products that are rapid test assays used in emergency care settings for the diagnosis of myocardial infarction; quantitative cardiac tests, a quantitative test measuring the concentration of the peptide NT-proBNP for the diagnosis of congestive heart failure; and pandemic influenza test that detects and differentiates the various strains of influenza, including potential pandemic strains. The company was founded in 1993 and is headquartered in San Diego, California. On May 13, 2009, Nanogen, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. Its diagnostic services include respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis, and pathogen. The company was founded by Jong-Yoon Chun on September 16, 2000 and is headquartered in Seoul, South Korea.

Verinata is driven by a sole, extraordinary purpose – maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today's multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata is conducting a prospective, blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test on a large scale with results of the study expected in 2011.

Applera Corp. manufactures medical instruments

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

BP SCI LLC distributes branded pipes, valves, and fittings. The company is headquartered in Dover, DE.

Part of MOH Holdings Pte Ltd., Singapore Health Services Pte Ltd. is a Singaporean company located in Singapore. The firm provides medical services. Ivy Ng is the CEO, in this role since 2012.

Anhui Differential Gene Technology Co., Ltd., established on 2017-06-28, The scope of business includes technology promotion in the field of gene life science,technical consulting,Technical service and technology transfer;Experimental instruments and supporting consumables,Electronic product development,Sales;Biological Reagent Sales;Information technology services and software services;Gene big data collection,Storage and analysis and mining related products and technical services;Production of Class I, Class II and Class III medical devices,Sales,Technology research and development and outsourcing services;Import and export of goods or technology(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)